Luca Marzi

1.4k total citations · 1 hit paper
19 papers, 720 citations indexed

About

Luca Marzi is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Luca Marzi has authored 19 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Luca Marzi's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (4 papers). Luca Marzi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (4 papers). Luca Marzi collaborates with scholars based in Italy, Spain and United States. Luca Marzi's co-authors include Eleonora Scaioli, Anna Rita Di Biase, Lucia Montrone, Antonio Colecchia, Davide Festi, Ramona Schiumerini, Agostino Colli, G. Mazzella, Maria Letizia Bacchi Reggiani and Laura Turco and has published in prestigious journals such as Gastroenterology, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Luca Marzi

17 papers receiving 709 citations

Hit Papers

Measurement of Spleen Stiffness to Evaluate Portal Hypert... 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Marzi Italy 9 565 481 153 71 67 19 720
Hidekatsu Kuroda Japan 18 597 1.1× 574 1.2× 142 0.9× 48 0.7× 50 0.7× 82 890
Gabriela Perdomo Coral Brazil 16 571 1.0× 446 0.9× 120 0.8× 80 1.1× 55 0.8× 55 756
Delphine Weil France 12 355 0.6× 370 0.8× 134 0.9× 43 0.6× 37 0.6× 36 566
Rania Elhelaly Egypt 14 381 0.7× 303 0.6× 197 1.3× 65 0.9× 81 1.2× 32 612
Jesús Castillo Spain 13 522 0.9× 500 1.0× 103 0.7× 130 1.8× 75 1.1× 26 872
Christian Mortensen Denmark 14 541 1.0× 390 0.8× 237 1.5× 43 0.6× 134 2.0× 30 869
Jeng‐Fu Yang Taiwan 17 813 1.4× 685 1.4× 76 0.5× 160 2.3× 52 0.8× 41 998
Kazuyuki Ohata Japan 9 538 1.0× 382 0.8× 121 0.8× 103 1.5× 101 1.5× 16 766
Lukas Hartl Austria 18 749 1.3× 735 1.5× 250 1.6× 70 1.0× 27 0.4× 75 951
Ankur Srivastava United Kingdom 10 583 1.0× 427 0.9× 109 0.7× 137 1.9× 58 0.9× 29 731

Countries citing papers authored by Luca Marzi

Since Specialization
Citations

This map shows the geographic impact of Luca Marzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Marzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Marzi more than expected).

Fields of papers citing papers by Luca Marzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Marzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Marzi. The network helps show where Luca Marzi may publish in the future.

Co-authorship network of co-authors of Luca Marzi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Marzi. A scholar is included among the top collaborators of Luca Marzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Marzi. Luca Marzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Marzi, Luca, et al.. (2024). Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver. International Journal of Molecular Sciences. 25(21). 11676–11676. 1 indexed citations
3.
Marzi, Luca, Andrea Mega, Stefano Gitto, et al.. (2022). Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC. Cancers. 14(14). 3332–3332. 13 indexed citations
4.
Mega, Andrea, Luca Marzi, Fabio Vittadello, et al.. (2022). Supervised Machine Learning Techniques For the Prediction of Hepatocellular Carcinoma Recurrence. 5(2).
5.
Mega, Andrea, et al.. (2021). Food and Nutrition in the Pathogenesis of Liver Damage. Nutrients. 13(4). 1326–1326. 29 indexed citations
6.
Marzi, Luca. (2021). "Will Artificial Intelligence Unveil Hepatocellular Carcinoma?". Biomedical Journal of Scientific & Technical Research. 35(4). 5 indexed citations
7.
Gitto, Stefano, Fabio Marra, Luca Marzi, et al.. (2020). Metabolic Disorders After Liver Transplantation. Metabolic Syndrome and Related Disorders. 19(2). 65–69. 9 indexed citations
8.
Russo, Francesco Paolo, Alberto Zanetto, Martina Gambato, et al.. (2019). Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance. Journal of Viral Hepatitis. 27(2). 188–194. 21 indexed citations
9.
Marzi, Luca, Rosina Maria Critelli, Cristian Caporali, et al.. (2019). Angiopoietin‐2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma. Hepatology. 70(2). 745–747. 5 indexed citations
10.
Magistri, Paolo, Luca Marzi, Simona Guérzoni, et al.. (2018). Impact of a Multidisciplinary Team on Alcohol Recidivism and Survival After Liver Transplant for Alcoholic Disease. Transplantation Proceedings. 51(1). 187–189. 29 indexed citations
11.
Sacco, Rodolfo, Alessandro Granito, Irene Bargellini, et al.. (2018). Clinical Outcomes with Long-Term Sorafenib Treatment of Patients with Hepatocellular Carcinoma: A Multicenter Real-Life Study. Future Oncology. 14(29). 3049–3058. 5 indexed citations
12.
Critelli, Rosina Maria, Fabiola Milosa, Elena Turola, et al.. (2017). Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study. Cell Death and Disease. 8(8). e3017–e3017. 44 indexed citations
13.
Cabibbo, Giuseppe, María Reig, Gennaro Gadaleta‐Caldarola, et al.. (2016). The Calm Before the Storm: A Report from the International Liver Cancer Association Congress 2015 – Part 1. Future Oncology. 12(3). 281–284. 3 indexed citations
14.
Sartini, Alessandro, Marcello Bianchini, Filippo Schepis, et al.. (2016). Complete resolution of non‐necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection. Clinical Case Reports. 4(2). 195–202. 3 indexed citations
15.
Cabibbo, Giuseppe, María Reig, Gennaro Gadaleta‐Caldarola, et al.. (2016). The Calm Before the Storm: A Report from the International Liver Cancer Association Congress 2015 – Part 2. Future Oncology. 12(3). 285–288.
16.
Colecchia, Antonio, Daniele Mandolesi, Agostino Colli, et al.. (2013). 22 SPLEEN AND LIVER STIFFNESS MEASUREMENT CAN PREDICT CLINICAL COMPLICATIONS IN COMPENSATED CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY. Journal of Hepatology. 58. S10–S10. 1 indexed citations
17.
Colecchia, Antonio, Lucia Montrone, Eleonora Scaioli, et al.. (2012). Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis. Gastroenterology. 143(3). 646–654. 370 indexed citations breakdown →
18.
Festi, Davide, Ramona Schiumerini, Luca Marzi, et al.. (2012). Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods. Alimentary Pharmacology & Therapeutics. 37(4). 392–400. 137 indexed citations
19.
Festi, Davide, Ramona Schiumerini, Luca Marzi, et al.. (2011). Gut Microbiota and Its Pathophysiology in Disease Paradigms. Digestive Diseases. 29(6). 518–524. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026